Dear Editor,
A 48-year-old female with poorly controlled diabetes mellitus (DM) presented herself with a five-day history of fever, chills, left flank pain and dysuria. On admission, her abdomen was mildly distended and tender over the left lumbar region. Laboratory data showed white blood cell count of 18.6×109/L with 91.7% neutrophils, serum creatinine at 223 μmol/L, C-reactive protein at 168 mg/L and glycosylated hemoglobin (HbA1c) at 14.1%. Urine analysis showed turbid appearance with obvious pyuria, hematuria and proteinuria. A renal ultrasound scan revealed potential signs of gas in the parenchyma of the left kidney. A non-contrast computed tomography (CT) scan of the abdomen demonstrated swelling of the left kidney with visible gas in the renal parenchyma (Fig. 1), radiologically associated with emphysematous pyelonephritis (EPN, Class 2). The patient underwent CT-guided percutaneous catheter drainage (PCD) and was treated with broad-spectrum intravenous antibiotics and rigorous blood sugar control. The urine and pus cultures showed significant growth of Escherichia coli (E. coli). From the above medical procedures, the patient improved significantly and was discharged with an excellent prognosis.
EPN is an uncommon, but acutely severe and life-threatening necrotizing kidney infection, which is characterized by gas accumulation
in the renal parenchyma, collecting system, or perinephric tissue1 , 2 , 4. The disease usually occurs in female patients with poorly controlled DM, with or without urinary tract obstruction1 , 2 , 4. E. coli is the most common pathogen, which has been extracted from urine or pus cultures in almost 70% of the patients4. EPN is a radiological diagnosis, with CT scan currently being the imaging procedure of choice for early diagnosis and assessment of the disease1 , 2 , 4. Importantly, PCD is now the most appropriate strategy and the gold standard in management of EPN2 , 3. Over the last two decades, improvements in management techniques have drastically reduced the mortality rate of EPN to 21%3 , 4.
Funding Statement
This work was partly supported by the Medical Education Research Project of Shanghai Jiao Tong University School of Medicine (No. YB130910)
Footnotes
This work was partly supported by the Medical Education Research Project of Shanghai Jiao Tong University School of Medicine (No. YB130910).
REFERENCES
- 1.Huang JJ, Tseng CC. Emphysematous pyelonephritis: clinicoradiological classification, management, prognosis, and pathogenesis. Arch Intern Med. 2000;160:797–805. doi: 10.1001/archinte.160.6.797. [DOI] [PubMed] [Google Scholar]
- 2.Pontin AR, Barnes RD. Current management of emphysematous pyelonephritis. Nat Rev Urol. 2009;6:272–279. doi: 10.1038/nrurol.2009.51. [DOI] [PubMed] [Google Scholar]
- 3.Somani BK, Nabi G, Thorpe P, Hussey J, Cook J, N'Dow J. Is percutaneous drainage the new gold standard in the management of emphysematous pyelonephritis? Evidence from a systematic review. J Urol. 2008;179:1844–1849. doi: 10.1016/j.juro.2008.01.019. [DOI] [PubMed] [Google Scholar]
- 4.Ubee SS, McGlynn L, Fordham M. Emphysematous pyelonephritis. BJU Int. 2011;107:1474–1478. doi: 10.1111/j.1464-410X.2010.09660.x. [DOI] [PubMed] [Google Scholar]